| Literature DB >> 33976544 |
Iliya P Amaza1, Amy M J O'Shea2,3, Spyridon Fortis1,3, Alejandro P Comellas1.
Abstract
PURPOSE: Visual assessment of computed tomography (CT) of the lung is routinely employed in the diagnosis of emphysema. Quantitative CT (QCT) can complement visual CT but must be well validated. QCT emphysema is defined as ≥5% of lung volume occupied by low attenuation areas ≤-950 Hounsfield units (LAA-950). Discordant visual and QCT assessments are not uncommon. We examined the association between visual and quantitative chest CT evaluation within a large cohort of subjects to identify variables that may explain discordant visual and QCT findings.Entities:
Keywords: Akaike information criterion; chest imaging; chronic obstructive pulmonary disease; interobserver agreement
Mesh:
Year: 2021 PMID: 33976544 PMCID: PMC8106452 DOI: 10.2147/COPD.S284477
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Comparison of University of Iowa Radiologists’ Readings with QCT
| Visual Emphysema (University of Iowa Radiologists) | Total | |||
|---|---|---|---|---|
| No Emphysema | Emphysema | |||
| QCT (≥5% LAA-950) | No emphysema | 438 | 320 | 758 |
| Emphysema | 157 | 306 | 463 | |
| Total | 595 | 626 | 1221 | |
Notes: % concordance: observed 0.61, expected 0.50. Kappa estimate: 0.22 (0.17,0.28). McNemar’s Chi-squared test with continuity correction = 55.02, p <0.0001.
Abbreviations: LAA-950, low attenuation area ≤−950 Hounsfield units; QCT, quantitative computed tomography.
Figure 1Overlap of discordant groups from comparisons of University of Iowa radiologists versus quantitative computed tomography (QCT) and COPDGene radiologists versus QCT. (A) Visual-only emphysema. (B) Quantitative-only emphysema.
Demographics and Baseline Assessments Grouped by the Agreement of Visual Assessments by University of Iowa Radiologists with QCT
| Concordant Emphysema (N = 306) | Concordant No Emphysema (N = 438) | Quantitative-Only Emphysema (N= 157) | Visual-Only Emphysema (N = 320) | P-valuea | |
|---|---|---|---|---|---|
| Mean age (SD) | 66.86 (7.44) | 62.82 (8.74) | 63.62 (7.55) | 63.85 (8.78) | |
| Female sex, n (%) | 110 (35.9) | 254 (58.0) | 60 (38.2) | 179 (55.9) | <0.001 |
| Non-white race, n (%) | 4 (1.3) | 7 (1.6) | 1 (0.6) | 5 (1.6) | 0.67 |
| BMI, mean (SD) | 27.76 (5.22) | 31.13 (6.57) | 30.40 (6.15) | 29.58 (5.71) | 0.35 |
| Smoking intensity, pack years, mean (SD) | 56.75 (26.62) | 35.33 (24.36) | 37.32 (21.09) | 48.17 (25.05) | <0.001 |
| Current smoker, n (%) | 74 (24.2) | 109 (24.9) | 25 (15.9) | 152 (47.5) | <0.001 |
| Chronic bronchitis | 62 (20.3) | 34 (7.8) | 11 (7.0) | 53 (16.6) | <0.01 |
| Asthma | 39 (12.7) | 33 (7.5) | 9 (5.7) | 36 (11.2) | 0.08 |
| CHF | 2 (0.7) | 10 (2.3) | 0 (0.0) | 14 (4.4) | 0.01 |
| Rheumatoid arthritis | 15 (4.9) | 8 (1.8) | 5 (3.2) | 17 (5.3) | 0.36 |
| % Emphysema | 15.64 (10.26) | 2.01 (1.39) | 8.36 (4.00) | 2.07 (1.40) | <0.001 |
| % Gas trapping | 36.34 (17.75) | 9.14 (6.36) | 21.03 (11.54) | 11.95 (8.62) | <0.001 |
| Subsegmental wall area % | 63.47 (2.16) | 62.39 (1.84) | 62.46 (1.75) | 63.51 (1.91) | <0.001 |
| FRC, % predicted | 114.41 (30.67) | 86.89 (14.44) | 92.22 (18.72) | 97.93 (19.10) | <0.001 |
| TLC, % predicted | 120.03 (15.22) | 107.41 (13.81) | 113.20 (12.70) | 111.17 (12.98) | 0.10 |
| Any emphysema | 280 (91.5) | 122 (27.9) | 50 (31.8) | 285 (89.1) | <0.001 |
| Centrilobular emphysema | 273 (89.2) | 98 (22.4) | 42 (26.8) | 260 (81.2) | <0.001 |
| Paraseptal emphysema | 176 (57.5) | 53 (12.1) | 22 (14.0) | 208 (65.0) | <0.001 |
| FEV1, % predicted (SD) | 66.81 (25.29) | 91.23 (16.11) | 93.20 (18.96) | 82.43 (16.85) | <0.001 |
| FVC, % predicted (SD) | 90.28 (17.31) | 90.11 (13.96) | 96.08 (14.23) | 89.31 (15.40) | <0.001 |
| Never smoker (control) | 0 (0.0) | 32 (7.3) | 1 (0.6) | 3 (0.9) | |
| PRISm | 5 (1.7) | 60 (13.7) | 4 (2.5) | 47 (14.7) | |
| GOLD 0 | 66 (21.8) | 286 (65.4) | 113 (72.0) | 134 (41.9) | |
| GOLD 1 | 42 (13.9) | 15 (3.4) | 15 (9.6) | 48 (15.0) | |
| GOLD 2 | 104 (34.3) | 40 (9.2) | 19 (12.1) | 76 (23.8) | |
| GOLD 3 | 64 (21.1) | 4 (0.9) | 4 (2.5) | 11 (3.4) | |
| GOLD 4 | 22 (7.3) | 0 (0.0) | 1 (0.6) | 1 (0.3) |
Note: aComparing discordant groups (quantitative-only emphysema vs visual-only emphysema).
Abbreviations: BMI, body mass index; CHF, congestive heart failure; COPDGene, Genetic Epidemiology of COPD study; CT, computed tomography; FEV1, forced expiratory volume in 1 second; FRC, functional residual capacity; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; PRISm, preserved ratio impaired spirometry; QCT, quantitative computed tomography; SD, standard deviation; TLC, total lung capacity.
Figure 2Examples of discordant assessments. (A) The computed tomography was visually interpreted as negative for emphysema but emphysema was identified quantitatively; axial multiplanar reformat (MPR) (upper left), low attenuation area (LAA) percentages by lung lobe (upper right), axial MPR with LAA overlay (lower left), and topographic MPR (lower right) provided. Quantitative measures correlated with spirometry in this participant. (B) Visual-only identified emphysema. Small areas identified quantitatively but were not above the LAA ≤950 Hounsfield units 5% threshold; axial MPR (upper left), LAA percentages by lung lobe (upper right), axial MPR with LAA overlay (lower left), and topographic MPR (lower right) provided. Quantitative measures also correlated with spirometry. Images courtesy of VIDA, Coralville, Iowa, USA.
Figure 3Factors associated with discordance (multivariable stepwise logistic regression) Adjusted analysis comparing quantitative-only emphysema and visual-only emphysema (University of Iowa). Variables tested but not retained in the final model: functional residual capacity percent predicted and chronic bronchitis.
Figure 4Sensitivity of visually-detected emphysema at various quantitative computed tomography diagnostic thresholds.
Multivariable Regression Models with AIC
| QCT Emphysema (≥5% LAA-950) | Visual Emphysema (University of Iowa) | Visual Emphysema (COPDGene Imaging Center) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient (95% CI) | P-value | AIC | Coefficient (95% CI) | P-value | AIC | Coefficient (95% CI) | P-value | AIC | |
| Functional Outcomes† | |||||||||
| mMRC dyspnea score | 0.47 (0.34 to 0.60) | <0.001 | 126 | 0.52 (0.39 to 0.65) | <0.001 | 113 | 0.45 (0.32 to 0.59) | <0.001 | 132 |
| SGRQ score | 6.65 (4.78 to 8.52) | <0.001 | 6649 | 8.70 (6.87 to 10.53) | <0.001 | 6612 | 7.30 (5.36 to 9.23) | <0.001 | 6643 |
| 6MWD | −36.60 (−73.88 to 0.68) | 0.05 | 13,853 | −113.87 (−150.38 to −77.36) | <0.001 | 13,820 | −108.68 (−146.83 to −70.53) | <0.001 | 13,826 |
| Complications‡ | |||||||||
| Total exacerbations | 2.32 (1.79–2.99) | <0.001 | 4121 | 2.88 (2.24–3.70) | <0.001 | 4097 | 2.55 (1.94–3.34) | <0.001 | 4119 |
| Total severe exacerbations | 3.11 (2.13–4.54) | <0.001 | 2057 | 3.61 (2.49–5.25) | <0.001 | 2049 | 2.65 (1.75–4.02) | <0.001 | 2072 |
| Mortality§ | 1.61 (1.13 to 2.28) | 0.008 | 1990 | 1.68 (1.16 to 2.44) | 0.006 | 1989 | 2.07 (1.33 to 3.21) | 0.001 | 1985 |
Notes: †Linear regression models. ‡ Zero-inflated negative binomial models including age and current smoking status at enrollment, sex, race, pack-years smoked, and body mass index; follow-up time was included as offset. § Cox proportional hazard regression analysis with age, sex, race, smoking status, smoking pack-years, and body mass index as covariates.
Abbreviations: 6MWD, six-minute walk distance; AIC, Akaike information criterion; COPDGene, Genetic Epidemiology of COPD study; LAA-950, low attenuation area ≤−950 Hounsfield units; mMRC, modified Medical Research Council; QCT, quantitative computed tomography; SGRQ, St. George’s Respiratory Questionnaire.